Earlier this year, Tenelia's generics followed Galvus generics, and the generic drug market for DPP-4 diabetes treatments began in earnest. According to the industry on the 19th, the Ministry of Health and Welfare recently disclosed the registration of Tenelia's generics next month. Tenelia of material patent is expired on October 25th.
A total of 37 items of next month to enter the generic market. DPP-4 inhibitor market has used a total of nine species of products had not been released, but a strong patent protection for markets are opening up generic. 18 current generic for Galvus are reimbursed. The DPP-4 generic market is expected to begin in earnest. As a result, it is analyzed that as competition among p